Glaxosmithkline | GSK - 债务



金融业
股票价格
GBP
资产
GBP 62.87B
现金及等价物
GBP 3.44B
销售成本
GBP 1.88B
流动资产
GBP 17.76B
流动负债
GBP 22.43B
债务
GBP 19.06B
股息收益率
GBP 4.47
EBIT
GBP 2.31B
EBITDA
GBP 2.77B
员工
GBP 69.4K
EPS每股收益
GBP 0.62
股本和储备
GBP 17.42B
销售毛利
GBP 5.75B
债务利息支出
GBP 192.73M
利息收入
GBP 22M
贷款资金
GBP 18.53B
市值
GBP 107.91B
净收入
GBP 1.74B
营业费用
GBP 5.34B
营业利润
GBP 2.29B
普通股股本
GBP 4.05B
PE价格收益
15.09
税前利润
GBP 2.14B
销售收入
GBP 10.09B
销售和管理费用
GBP 2.12B
股票
GBP 6.16B
贸易债权人
GBP 14.34B
应收帐款人
GBP 10.49B


债务 更改 日
AbbVie USD 72.86B 5.36B 2026-03
Amgen USD 57.32B 2.72B 2026-03
AstraZeneca USD 32.24B 1.68B 2026-06
Aurora Cannabis CAD 23.86M 76.48M 2026-03
Bausch Health Companies USD 20.78B 16M 2026-06
Bristol-Myers Squibb USD 46.43B 711M 2026-03
Canopy Growth CAD 278.71M 19.38M 2026-03
Corcept Therapeutics USD 9.64M 3.53M 2026-03
Drreddys Laboratories INR 77.34B 9.61B 2026-03
Eli Lilly USD 43.37B 867M 2026-03
GlaxoSmithKline GBP 19.06B 1.34B 2026-03
Glaxosmithkline GBP 19.06B 1.31B 2026-03
J&J USD 54.99B 7.05B 2026-03
Merck USD 49.12B 222M 2026-03
Novartis USD 49.01B 2.02B 2026-06
Pacira USD 363.12M 4.53M 2026-06
Perrigo USD 3.63B 7.7M 2026-03
Pfizer USD 63.19B 536M 2026-06
Phibro Animal Health USD 474.17M 730K 2024-09
Prestige Brands USD 1.05B 33.86M 2026-03
Roche Holding CHF 33.03B 1.41B 2025-06
Sanofi EUR 23.58B 3.56B 2026-06
Supernus Pharmaceuticals USD 40.17M 733K 2026-06
Takeda JPY 4.94T 58.13B 2026-06
Teva Pharmaceutical Industries USD 16.91B 187M 2026-03
Zoetis USD 9.24B 0 2026-03